secwatch.observer — SEC 8-K summary
======================================

Issuer:     AMGEN INC (AMGN)
CIK:        0000318154
Form:       8-K
Filed at:   2021-07-30T23:59:59+00:00
Accession:  0001193125-21-229599
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Amgen appoints former Medtronic CEO S. Omar Ishrak to Board of Directors
------------------------------------------------------------------------

- S. Omar Ishrak appointed to Amgen Board effective July 29, 2021; will serve on Corporate Responsibility & Compliance and Compensation & Management Development committees.
- Ishrak was CEO and Chairman of Medtronic (2011-2020) and currently chairs Intel Corporation's Board.
- Board now consists of 12 directors, 11 of whom are independent.
- Ishrak receives pro-rata annual retainer of $105,000 and committee retainers of $12,500, plus pro-rata restricted stock unit grant valued at $210,000.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/318154/000119312521229599/0001193125-21-229599-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/318154/000119312521229599/d198092d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-21-229599

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer